Qiming U.S. Ventures Management as of June 30, 2022
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 7 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Icosavax | 27.9 | $20M | 3.5M | 5.73 | |
| Talaris Therapeutics | 18.4 | $13M | 2.9M | 4.51 | |
| Jasper Therapeutics | 15.7 | $11M | 5.9M | 1.93 | |
| Ventyx Biosciences (VTYX) | 15.5 | $11M | 910k | 12.23 | |
| Kezar Life Sciences (KZR) | 9.5 | $6.9M | 829k | 8.27 | |
| Hillevax (HLVX) | 8.5 | $6.1M | 559k | 10.93 | |
| Elevation Oncology (ELEV) | 4.6 | $3.3M | 2.4M | 1.40 |
